Press release
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea
Download Free Sample of Report- https://www.globalinsightservices.com/request-sample/GIS31258
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe.
Dysmenorrhea is thought to be caused by the release of prostaglandins, hormones that are involved in the regulation of pain and inflammation.
Primary Dysmenorrhea is diagnosed by symptoms like lower pelvic or abdominal pain and is usually associated with the onset of menstrual flow and lasts 8-72 hours. Secondary Dysmenorrhea is diagnosed with symptoms like a change in the time of pain onset during the menstrual cycle or in the intensity of pain along with pelvic abnormality on physical examination.
There are several treatments available for dysmenorrhea. These include over-the-counter pain relievers such as ibuprofen or naproxen, birth control pills, and, in some cases, surgery.
Request For Customization - https://www.globalinsightservices.com/request-customization/GIS31258
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Dysmenorrhea treatment such as FSN-013, Linzagolix, Relugolix and others. Key players involved in the development of therapies to treat Dysmenorrhea are Fuji Pharma Japan Inc, Latitude Pharmaceuticals Inc, Myovant Sciences GmbH, ObsEva SA, PNB Vesper Life Sciences and others. Three drugs are under late-stage Phase III clinical trials and one drug are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development.
Report Highlights
Global Insight Service's, Dysmenorrhea - Drug Pipeline Landscape, 2023 report provides an overview of the Dysmenorrhea pipeline drugs. This report covers detailed insights on Dysmenorrhea drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Dysmenorrhea pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
For In-Depth Competitive Analysis, Purchase this Report- https://www.globalinsightservices.com/inquiry-before-buying/GIS3125
Reasons to Buy
Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dysmenorrhea - Drug Pipeline Landscape, 2022 here
News-ID: 2900914 • Views: …
More Releases from Global Insight Services
Gene Editing Service Market Expected to Expand From $2.8 Billion in 2024 to $9.7 …
The Gene Editing Service Market is witnessing rapid growth, driven by advancements in biotechnology and increased demand for precise genetic modification solutions. This market focuses on providing services and technologies for altering genetic material with high accuracy, enabling transformative applications in therapeutics, agriculture, and industrial biotechnology. Tools such as CRISPR-Cas9, TALENs, and Zinc Finger Nucleases are central to this market, offering tailored solutions for gene knockouts, knock-ins, and other modifications.…
Epigenomics Market Projected to Reach $11.6 Billion by 2034, Growing at 13.1% CA …
The Epigenomics Market is evolving as one of the most promising areas in modern healthcare and biotechnology. Unlike traditional genetics, epigenomics focuses on changes in gene expression without altering the DNA sequence itself. This science studies mechanisms such as DNA methylation, histone modification, and non-coding RNA, which influence how genes behave. With applications spanning oncology, neurology, cardiology, and drug development, the epigenomics market is becoming central to personalized medicine. It…
E-invoicing Market Is Anticipated To Expand From $18.6 Billion In 2024 To $78.9 …
Market Overview
The E-invoicing Market is undergoing a major transformation as businesses worldwide shift towards digital and automated financial processes. The market is anticipated to expand from $18.6 billion in 2024 to $78.9 billion by 2034, growing at an impressive CAGR of approximately 15.5%. This growth reflects the global trend of digitization and the increasing need for transparency, efficiency, and compliance in financial operations. E-invoicing-short for electronic invoicing-replaces traditional paper-based billing…
Eco Friendly Food Packaging Market Is Anticipated To Expand From $380.4 Billion …
Market Overview
The Eco friendly Food Packaging Market is rapidly transforming the global food industry by promoting sustainability and reducing environmental impact. As consumers and governments alike emphasize green practices, companies are shifting from traditional plastic packaging to biodegradable, recyclable, and compostable alternatives. These sustainable materials include paper, cardboard, and plant-based plastics that help minimize waste generation and carbon footprints. The market supports the transition toward a circular economy, encouraging brands…
More Releases for Dysmenorrhea
Dysmenorrhea Market Share, Epidemiology, Analysis & Trends 2023-2033
Market Overview:
The dysmenorrhea market is expected to exhibit a CAGR of 5.67% during 2023-2033. The dysmenorrhea market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of menstru*tion and last for the first few days of…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of and last for the first few days of…
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Survey and 2027 Foresight Report
Dysmenorrhea Treatment: Market Overview
Globally, more than 50% of post pubescent menstruating women are affected by dysmenorrhea, with 10–12% of them having severe dysmenorrhea with incapacitation for 1–3 days each month. Because young women constitute a significant percentage of the adult work force in the US, nearby 600 million working hours or 2 billion dollars are lost annually because of incapacitating dysmenorrhea if adequate relief is not provided. Women who continue…
